Updated 2026-05-15
| Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc. Class A Common Stock | DNA | 5 | 4 | 1 | 20.0 |
| Alvotech - Ordinary Shares | ALVO | 11 | 10 | 1 | 9.1 |
| Iovance Biotherapeutics, Inc. - Common Stock | IOVA | 9 | 7 | 2 | 22.2 |
| Alnylam Pharmaceuticals, Inc. - Common Stock | ALNY | 4 | 4 | 0 | 0.0 |
| Tempus AI, Inc. - Class A Common Stock | TEM | 10 | 10 | 0 | 0.0 |
| Pacific Biosciences of California, Inc. - Common Stock | PACB | 7 | 7 | 0 | 0.0 |
| Annexon, Inc. - common stock | ANNX | 5 | 4 | 1 | 20.0 |
| Regeneron Pharmaceuticals, Inc. - Common Stock | REGN | 4 | 3 | 1 | 25.0 |
| AbCellera Biologics Inc. - Common Shares | ABCL | 8 | 7 | 1 | 12.5 |
| Veracyte, Inc. - Common Stock | VCYT | 8 | 6 | 2 | 25.0 |
| Catalyst Pharmaceuticals, Inc. - Common Stock | CPRX | 7 | 4 | 3 | 42.9 |
| CG Oncology, Inc. - Common stock | CGON | 5 | 4 | 1 | 20.0 |
| Spyre Therapeutics, Inc. - Common Stock | SYRE | 3 | 1 | 2 | 66.7 |
| Natera, Inc. - Common Stock | NTRA | 8 | 7 | 1 | 12.5 |
| Cogent Biosciences, Inc. - Common Stock | COGT | 12 | 7 | 5 | 41.7 |
| Alumis Inc. - Common Stock | ALMS | 5 | 4 | 1 | 20.0 |
| Damora Therapeutics, Inc. - Common Stock | DMRA | 0 | 0 | 0 | 0.0 |
| AnaptysBio, Inc. - Common Stock | ANAB | 2 | 0 | 2 | 100.0 |
| BioNTech SE - American Depositary Shares | BNTX | 14 | 13 | 1 | 7.1 |
| Theravance Biopharma, Inc. - Ordinary Shares | TBPH | 8 | 5 | 3 | 37.5 |
| Definium Therapeutics, Inc. - Common Shares | DFTX | 5 | 3 | 2 | 40.0 |
| ACADIA Pharmaceuticals Inc. - Common Stock | ACAD | 7 | 6 | 1 | 14.3 |
| Zenas BioPharma, Inc. - Common Stock | ZBIO | 3 | 3 | 0 | 0.0 |
| Tyra Biosciences, Inc. - Common Stock | TYRA | 2 | 1 | 1 | 50.0 |
| Quanterix Corporation - Common Stock | QTRX | 3 | 3 | 0 | 0.0 |
| Capricor Therapeutics, Inc. - Common Stock | CAPR | 8 | 6 | 2 | 25.0 |
| MeiraGTx Holdings plc - Ordinary Shares | MGTX | 6 | 5 | 1 | 16.7 |
| AbbVie Inc. Common Stock | ABBV | 5 | 5 | 0 | 0.0 |
| Olema Pharmaceuticals, Inc. - Common Stock | OLMA | 6 | 4 | 2 | 33.3 |
| MiMedx Group, Inc - Common Stock | MDXG | 2 | 2 | 0 | 0.0 |
| Cabaletta Bio, Inc. - Common Stock | CABA | 4 | 3 | 1 | 25.0 |
| Amgen Inc. - Common Stock | AMGN | 6 | 5 | 1 | 16.7 |
| BridgeBio Pharma, Inc. - Common Stock | BBIO | 9 | 6 | 3 | 33.3 |
| Prothena Corporation plc - Ordinary Shares | PRTA | 2 | 1 | 1 | 50.0 |
| Kodiak Sciences Inc - Common Stock | KOD | 6 | 2 | 4 | 66.7 |
| Dianthus Therapeutics, Inc. - Common Stock | DNTH | 4 | 2 | 2 | 50.0 |
| Biogen Inc. - Common Stock | BIIB | 9 | 7 | 2 | 22.2 |
| NovoCure Limited - Ordinary Shares | NVCR | 10 | 8 | 2 | 20.0 |
| PTC Therapeutics, Inc. - Common Stock | PTCT | 7 | 6 | 1 | 14.3 |
| Sarepta Therapeutics, Inc. - Common Stock | SRPT | 5 | 3 | 2 | 40.0 |
| Relay Therapeutics, Inc. - Common Stock | RLAY | 3 | 2 | 1 | 33.3 |
| KalVista Pharmaceuticals, Inc. - Common Stock | KALV | 5 | 4 | 1 | 20.0 |
| First Tracks Biotherapeutics, Inc. - Ordinary Shares | TRAX | 0 | 0 | 0 | 0.0 |
| Recursion Pharmaceuticals, Inc. - Class A Common Stock | RXRX | 9 | 9 | 0 | 0.0 |
| Absci Corporation - Common Stock | ABSI | 6 | 5 | 1 | 16.7 |
| Immunome, Inc. - Common Stock | IMNM | 6 | 5 | 1 | 16.7 |
| Disc Medicine, Inc. - Common Stock | IRON | 2 | 2 | 0 | 0.0 |
| Sionna Therapeutics, Inc. - Common Stock | SION | 3 | 3 | 0 | 0.0 |
| Candel Therapeutics, Inc. - Common Stock | CADL | 7 | 5 | 2 | 28.6 |
| Genmab A/S - American Depositary Shares | GMAB | 36 | 31 | 5 | 13.9 |
| Bicycle Therapeutics plc - American Depositary Shares | BCYC | 0 | 0 | 0 | 0.0 |
| PepGen Inc. - Common Stock | PEPG | 3 | 3 | 0 | 0.0 |
| Xenon Pharmaceuticals Inc. - Common Shares | XENE | 4 | 2 | 2 | 50.0 |
| Tarsus Pharmaceuticals, Inc. - Common Stock | TARS | 5 | 4 | 1 | 20.0 |
| Vertex Pharmaceuticals Incorporated - Common Stock | VRTX | 6 | 6 | 0 | 0.0 |
| Castle Biosciences, Inc. - Common stock | CSTL | 5 | 4 | 1 | 20.0 |
| Centessa Pharmaceuticals plc - American Depositary Shares | CNTA | 2 | 1 | 1 | 50.0 |
| Solid Biosciences Inc. - Common Stock | SLDB | 7 | 5 | 2 | 28.6 |
| NewAmsterdam Pharma Company N.V. - Ordinary Shares | NAMS | 2 | 1 | 1 | 50.0 |
| Inhibrx Biosciences, Inc. - Common Stock | INBX | 7 | 3 | 4 | 57.1 |
| Phathom Pharmaceuticals, Inc. - Common Stock | PHAT | 6 | 5 | 1 | 16.7 |
| Quantum-Si Incorporated - Class A Common Stock | QSI | 8 | 6 | 2 | 25.0 |
| CytomX Therapeutics, Inc. - Common Stock | CTMX | 1 | 1 | 0 | 0.0 |
| Palvella Therapeutics, Inc. - Common Stock | PVLA | 7 | 5 | 2 | 28.6 |
| GRAIL, Inc. - Common Stock | GRAL | 9 | 9 | 0 | 0.0 |
| Travere Therapeutics, Inc. - Common Stock | TVTX | 5 | 3 | 2 | 40.0 |
| Enanta Pharmaceuticals, Inc. - Common Stock | ENTA | 5 | 3 | 2 | 40.0 |
| Alkermes plc - Ordinary Shares | ALKS | 7 | 5 | 2 | 28.6 |
| Akebia Therapeutics, Inc. - Common Stock | AKBA | 1 | 1 | 0 | 0.0 |
| Jyong Biotech Ltd. - Ordinary shares | MENS | 1 | 1 | 0 | 0.0 |
| Adaptive Biotechnologies Corporation - Common Stock | ADPT | 7 | 7 | 0 | 0.0 |
| Stevanato Group S.p.A. Ordinary Shares | STVN | 4 | 3 | 1 | 25.0 |
| NovaBridge Biosciences - American Depositary Shares | NBP | 5 | 5 | 0 | 0.0 |
| Lineage Cell Therapeutics, Inc. Common Stock | LCTX | 3 | 3 | 0 | 0.0 |
| 10x Genomics, Inc. - Common Stock | TXG | 9 | 7 | 2 | 22.2 |
| Maravai LifeSciences Holdings, Inc. - Class A common stock | MRVI | 6 | 3 | 3 | 50.0 |
| Immutep Limited - American Depositary Shares | IMMP | 8 | 7 | 1 | 12.5 |
| Gilead Sciences, Inc. - Common Stock | GILD | 6 | 5 | 1 | 16.7 |
| AC Immune SA - Common Stock | ACIU | 1 | 1 | 0 | 0.0 |
| Alpha Teknova, Inc. - Common Stock | TKNO | 1 | 0 | 1 | 100.0 |
| Grifols, S.A. - American Depositary Shares | GRFS | 19 | 18 | 1 | 5.3 |
| Opko Health, Inc. - Common Stock | OPK | 0 | 0 | 0 | 0.0 |
| Zevra Therapeutics, Inc. - Common Stock | ZVRA | 4 | 4 | 0 | 0.0 |
| Replimune Group, Inc. - Common Stock | REPL | 5 | 4 | 1 | 20.0 |
| Beam Therapeutics Inc. - Common Stock | BEAM | 7 | 6 | 1 | 14.3 |
| BioMarin Pharmaceutical Inc. - Common Stock | BMRN | 3 | 3 | 0 | 0.0 |
| Emergent BioSolutions Inc. Common Stock | EBS | 12 | 10 | 2 | 16.7 |
| Structure Therapeutics Inc. - American Depositary Shares | GPCR | 4 | 2 | 2 | 50.0 |
| Ascendis Pharma A/S - Ordinary Share | ASND | 1 | 1 | 0 | 0.0 |
| ADMA Biologics Inc - Common Stock | ADMA | 4 | 4 | 0 | 0.0 |
| Perspective Therapeutics, Inc. Common Stock | CATX | 2 | 2 | 0 | 0.0 |
| Sana Biotechnology, Inc. - Common Stock | SANA | 4 | 4 | 0 | 0.0 |
| Altimmune, Inc. - Common Stock | ALT | 5 | 4 | 1 | 20.0 |
| Krystal Biotech, Inc. - Common Stock | KRYS | 5 | 3 | 2 | 40.0 |
| OmniAb, Inc. - Common Stock | OABI | 3 | 2 | 1 | 33.3 |
| Vir Biotechnology, Inc. - Common Stock | VIR | 7 | 3 | 4 | 57.1 |
| Foghorn Therapeutics Inc. - Common Stock | FHTX | 5 | 5 | 0 | 0.0 |
| Verastem, Inc. - Common Stock | VSTM | 2 | 2 | 0 | 0.0 |
| 4D Molecular Therapeutics, Inc. - Common Stock | FDMT | 8 | 7 | 1 | 12.5 |
| Nurix Therapeutics, Inc. - Common stock | NRIX | 4 | 4 | 0 | 0.0 |
| argenx SE - American Depositary Shares | ARGX | 17 | 13 | 4 | 23.5 |
| Illumina, Inc. - Common Stock | ILMN | 2 | 1 | 1 | 50.0 |
| Cellectis S.A. - American Depositary Shares | CLLS | 23 | 19 | 4 | 17.4 |
| Nuvalent, Inc. - Class A Common Stock | NUVL | 1 | 1 | 0 | 0.0 |
| Taysha Gene Therapies, Inc. - Common Stock | TSHA | 10 | 7 | 3 | 30.0 |
| Halozyme Therapeutics, Inc. - Common Stock | HALO | 4 | 1 | 3 | 75.0 |
| Tenaya Therapeutics, Inc. - Common Stock | TNYA | 6 | 4 | 2 | 33.3 |
| Twist Bioscience Corporation - Common Stock | TWST | 9 | 7 | 2 | 22.2 |
| Neumora Therapeutics, Inc. - Common Stock | NMRA | 3 | 3 | 0 | 0.0 |
| Vera Therapeutics, Inc. - Class A Common Stock | VERA | 6 | 5 | 1 | 16.7 |
| Amylyx Pharmaceuticals, Inc. - Common Stock | AMLX | 5 | 3 | 2 | 40.0 |
| Aura Biosciences, Inc. - Common Stock | AURA | 3 | 3 | 0 | 0.0 |
| Biohaven Ltd. Common Shares | BHVN | 4 | 4 | 0 | 0.0 |
| Aurinia Pharmaceuticals Inc - Common Shares | AUPH | 6 | 6 | 0 | 0.0 |
| Oruka Therapeutics, Inc. - Common Stock | ORKA | 8 | 5 | 3 | 37.5 |
| Ultragenyx Pharmaceutical Inc. - Common Stock | RARE | 1 | 1 | 0 | 0.0 |
| Rigel Pharmaceuticals, Inc. - Common Stock | RIGL | 6 | 4 | 2 | 33.3 |
| Autolus Therapeutics plc - American Depositary Shares | AUTL | 6 | 6 | 0 | 0.0 |
| BeOne Medicines Ltd. - American Depositary Shares | ONC | 30 | 24 | 6 | 20.0 |
| Humacyte, Inc. - Common Stock | HUMA | 4 | 3 | 1 | 25.0 |
| Summit Therapeutics Inc. - Common Stock | SMMT | 3 | 3 | 0 | 0.0 |
| GH Research PLC - Ordinary Shares | GHRS | 4 | 2 | 2 | 50.0 |
| Dyne Therapeutics, Inc. - Common Stock | DYN | 6 | 6 | 0 | 0.0 |
| Upstream Bio, Inc. - Common Stock | UPB | 2 | 2 | 0 | 0.0 |
| Viking Therapeutics, Inc. - Common Stock | VKTX | 7 | 7 | 0 | 0.0 |
| Contineum Therapeutics, Inc. - Common stock | CTNM | 2 | 1 | 1 | 50.0 |
| Moderna, Inc. - Common Stock | MRNA | 11 | 10 | 1 | 9.1 |
| Stoke Therapeutics, Inc. - Common Stock | STOK | 5 | 5 | 0 | 0.0 |
| Axsome Therapeutics, Inc. - Common Stock | AXSM | 5 | 5 | 0 | 0.0 |
| Corvus Pharmaceuticals, Inc. - Common Stock | CRVS | 4 | 3 | 1 | 25.0 |
| Fortrea Holdings Inc. - Common Stock | FTRE | 11 | 8 | 3 | 27.3 |
| Rocket Pharmaceuticals, Inc. - Common Stock | RCKT | 8 | 8 | 0 | 0.0 |
| Kyverna Therapeutics, Inc. - Common Stock | KYTX | 8 | 7 | 1 | 12.5 |
| Prime Medicine, Inc. - Common Stock | PRME | 5 | 4 | 1 | 20.0 |
| Fulcrum Therapeutics, Inc. - Common Stock | FULC | 3 | 3 | 0 | 0.0 |
| CRISPR Therapeutics AG - Common Shares | CRSP | 11 | 11 | 0 | 0.0 |
| Mineralys Therapeutics, Inc. - Common Stock | MLYS | 3 | 2 | 1 | 33.3 |
| Janux Therapeutics, Inc. - Common Stock | JANX | 5 | 5 | 0 | 0.0 |
| Aclaris Therapeutics, Inc. - Common Stock | ACRS | 4 | 2 | 2 | 50.0 |
| Vericel Corporation - Common Stock | VCEL | 4 | 3 | 1 | 25.0 |
| Cytokinetics, Incorporated - Common Stock | CYTK | 4 | 2 | 2 | 50.0 |
| Oric Pharmaceuticals, Inc. - Common Stock | ORIC | 5 | 4 | 1 | 20.0 |
| Neurogene Inc. - Common Stock | NGNE | 4 | 3 | 1 | 25.0 |
| Charles River Laboratories International, Inc. Common Stock | CRL | 7 | 7 | 0 | 0.0 |
| Pharvaris N.V. - Ordinary Shares | PHVS | 0 | 0 | 0 | 0.0 |
| uniQure N.V. - Ordinary Shares | QURE | 9 | 9 | 0 | 0.0 |
| Cytek Biosciences, Inc. - Common Stock | CTKB | 4 | 3 | 1 | 25.0 |
| Erasca, Inc. - Common Stock | ERAS | 2 | 2 | 0 | 0.0 |
| Arrowhead Pharmaceuticals, Inc. - Common Stock | ARWR | 11 | 7 | 4 | 36.4 |
| CareDx, Inc. - Common Stock | CDNA | 6 | 5 | 1 | 16.7 |
| Novavax, Inc. - Common Stock | NVAX | 8 | 6 | 2 | 25.0 |
| Wave Life Sciences Ltd. - Ordinary Shares | WVE | 5 | 5 | 0 | 0.0 |
| Lexeo Therapeutics, Inc. - Common Stock | LXEO | 3 | 3 | 0 | 0.0 |
| Aardvark Therapeutics, Inc. - Common Stock | AARD | 3 | 3 | 0 | 0.0 |
| Gossamer Bio, Inc. - Common Stock | GOSS | 3 | 3 | 0 | 0.0 |
| Bio-Techne Corp - Common Stock | TECH | 3 | 3 | 0 | 0.0 |
| Entrada Therapeutics, Inc. - Common Stock | TRDA | 5 | 5 | 0 | 0.0 |
| BioCryst Pharmaceuticals, Inc. - Common Stock | BCRX | 1 | 1 | 0 | 0.0 |
| Zymeworks Inc. - Common Stock | ZYME | 6 | 4 | 2 | 33.3 |
| ArriVent BioPharma, Inc. - Common Stock | AVBP | 3 | 3 | 0 | 0.0 |
| Fulgent Genetics, Inc. - Common Stock | FLGT | 6 | 6 | 0 | 0.0 |
| Ironwood Pharmaceuticals, Inc. - Class A Common Stock | IRWD | 6 | 3 | 3 | 50.0 |
| Myriad Genetics, Inc. - Common Stock | MYGN | 1 | 1 | 0 | 0.0 |
| Arcturus Therapeutics Holdings Inc. - Common Stock | ARCT | 3 | 3 | 0 | 0.0 |
| Viridian Therapeutics, Inc. - Common Stock | VRDN | 6 | 5 | 1 | 16.7 |
| Exelixis, Inc. - Common Stock | EXEL | 6 | 4 | 2 | 33.3 |
| Apogee Therapeutics, Inc. - Common Stock | APGE | 6 | 4 | 2 | 33.3 |
| Kymera Therapeutics, Inc. - Common Stock | KYMR | 5 | 4 | 1 | 20.0 |
| Crinetics Pharmaceuticals, Inc. - Common Stock | CRNX | 6 | 5 | 1 | 16.7 |
| Zai Lab Limited - American Depositary Shares | ZLAB | 30 | 30 | 0 | 0.0 |
| Immuneering Corporation - Class A Common Stock | IMRX | 5 | 3 | 2 | 40.0 |
| Lakefront Biotherapeutics - American Depositary Shares | LKFT | 0 | 0 | 0 | 0.0 |
| Atea Pharmaceuticals, Inc. - common stock | AVIR | 1 | 1 | 0 | 0.0 |
| Abivax SA - American Depositary Shares | ABVX | 13 | 9 | 4 | 30.8 |
| Arcutis Biotherapeutics, Inc. - Common stock | ARQT | 3 | 3 | 0 | 0.0 |
| MannKind Corporation - Common Stock | MNKD | 5 | 4 | 1 | 20.0 |
| Praxis Precision Medicines, Inc. - Common Stock | PRAX | 4 | 1 | 3 | 75.0 |
| Ardelyx, Inc. - Common Stock | ARDX | 12 | 8 | 4 | 33.3 |
| Vaxcyte, Inc. - Common Stock | PCVX | 4 | 4 | 0 | 0.0 |
| Editas Medicine, Inc. - Common Stock | EDIT | 1 | 1 | 0 | 0.0 |
| Geron Corporation - Common Stock | GERN | 1 | 1 | 0 | 0.0 |
| Tango Therapeutics, Inc. - Common Stock | TNGX | 2 | 2 | 0 | 0.0 |
| Insmed Incorporated - Common Stock | INSM | 5 | 4 | 1 | 20.0 |
| BridgeBio Oncology Therapeutics, Inc. - Common Stock | BBOT | 1 | 1 | 0 | 0.0 |
| Scholar Rock Holding Corporation - Common Stock | SRRK | 4 | 2 | 2 | 50.0 |
| Keros Therapeutics, Inc. - common stock | KROS | 5 | 5 | 0 | 0.0 |
| Repligen Corporation - Common Stock | RGEN | 10 | 10 | 0 | 0.0 |
| Bicara Therapeutics Inc. - Common Stock | BCAX | 1 | 1 | 0 | 0.0 |
| AtaiBeckley Inc. - Common Stock | ATAI | 7 | 5 | 2 | 28.6 |
| ADC Therapeutics SA Common Shares | ADCT | 0 | 0 | 0 | 0.0 |
| Silence Therapeutics Plc - American Depository Share | SLN | 2 | 2 | 0 | 0.0 |
| Hyperliquid Strategies Inc - Common Stock | PURR | 10 | 8 | 2 | 20.0 |
| Monte Rosa Therapeutics, Inc. - Common Stock | GLUE | 6 | 4 | 2 | 33.3 |
| Edgewise Therapeutics, Inc. - Common Stock | EWTX | 3 | 2 | 1 | 33.3 |
| Arvinas, Inc. - Common Stock | ARVN | 8 | 7 | 1 | 12.5 |
| Caribou Biosciences, Inc. - Common Stock | CRBU | 1 | 1 | 0 | 0.0 |
| Lyell Immunopharma, Inc. - Common Stock | LYEL | 3 | 3 | 0 | 0.0 |
| Denali Therapeutics Inc. - Common Stock | DNLI | 6 | 6 | 0 | 0.0 |
| Ocugen, Inc. - Common Stock | OCGN | 5 | 3 | 2 | 40.0 |
| UroGen Pharma Ltd. - Ordinary Shares | URGN | 4 | 0 | 4 | 100.0 |
| Soleno Therapeutics, Inc. - Common Stock | SLNO | 3 | 2 | 1 | 33.3 |
| Nuvation Bio Inc. Class A Common Stock | NUVB | 6 | 4 | 2 | 33.3 |
| Celldex Therapeutics, Inc. - Common Stock | CLDX | 6 | 5 | 1 | 16.7 |
| Precigen, Inc. - Common Stock | PGEN | 8 | 5 | 3 | 37.5 |
| C4 Therapeutics, Inc. - Common Stock | CCCC | 4 | 4 | 0 | 0.0 |
| Madrigal Pharmaceuticals, Inc. - Common Stock | MDGL | 1 | 1 | 0 | 0.0 |
| Design Therapeutics, Inc. - Common Stock | DSGN | 3 | 2 | 1 | 33.3 |
| Anavex Life Sciences Corp. - Common Stock | AVXL | 2 | 2 | 0 | 0.0 |
| Personalis, Inc. - Common Stock | PSNL | 6 | 5 | 1 | 16.7 |
| Mirum Pharmaceuticals, Inc. - common stock | MIRM | 4 | 0 | 4 | 100.0 |
| Compass Therapeutics, Inc. - Common Stock | CMPX | 2 | 2 | 0 | 0.0 |
| Septerna, Inc. - Common Stock | SEPN | 5 | 4 | 1 | 20.0 |
| Black Diamond Therapeutics, Inc. - Common Stock | BDTX | 2 | 2 | 0 | 0.0 |
| Tectonic Therapeutic, Inc. - Common Stock | TECX | 1 | 1 | 0 | 0.0 |
| Invivyd, Inc. - Common Stock | IVVD | 5 | 4 | 1 | 20.0 |
| Trevi Therapeutics, Inc. - Common Stock | TRVI | 1 | 0 | 1 | 100.0 |
| Syndax Pharmaceuticals, Inc. - Common Stock | SNDX | 5 | 2 | 3 | 60.0 |
| Protagonist Therapeutics, Inc. - Common Stock | PTGX | 0 | 0 | 0 | 0.0 |
| Intellia Therapeutics, Inc. - Common Stock | NTLA | 6 | 6 | 0 | 0.0 |
| Arcus Biosciences, Inc. Common Stock | RCUS | 6 | 3 | 3 | 50.0 |
| Codexis, Inc. - Common Stock | CDXS | 6 | 3 | 3 | 50.0 |
| SELLAS Life Sciences Group, Inc. - Common Stock | SLS | 6 | 3 | 3 | 50.0 |
| TG Therapeutics, Inc. - Common Stock | TGTX | 4 | 2 | 2 | 50.0 |
| Agios Pharmaceuticals, Inc. - Common Stock | AGIO | 3 | 2 | 1 | 33.3 |
| Standard BioTools Inc. - Common Stock | LAB | 4 | 4 | 0 | 0.0 |
| Pyxis Oncology, Inc. - Common Stock | PYXS | 1 | 1 | 0 | 0.0 |
| Larimar Therapeutics, Inc. - Common Stock | LRMR | 2 | 1 | 1 | 50.0 |
| Arbutus Biopharma Corporation - Common Stock | ABUS | 5 | 5 | 0 | 0.0 |
| Bruker Corporation - Common Stock | BRKR | 7 | 6 | 1 | 14.3 |
| MBX Biosciences, Inc. - Common Stock | MBX | 3 | 1 | 2 | 66.7 |
| Neurocrine Biosciences, Inc. - Common Stock | NBIX | 7 | 6 | 1 | 14.3 |
| Voyager Therapeutics, Inc. - Common Stock | VYGR | 2 | 2 | 0 | 0.0 |
| Immunovant, Inc. - Common Stock | IMVT | 3 | 1 | 2 | 66.7 |
| Vor Biopharma Inc. - Common Stock | VOR | 7 | 6 | 1 | 14.3 |
| Revolution Medicines, Inc. - Common Stock | RVMD | 8 | 0 | 8 | 100.0 |
| Legend Biotech Corporation - American Depositary Shares | LEGN | 3 | 2 | 1 | 33.3 |
| IDEAYA Biosciences, Inc. - Common Stock | IDYA | 5 | 5 | 0 | 0.0 |
| ARS Pharmaceuticals, Inc. - Common Stock | SPRY | 1 | 1 | 0 | 0.0 |
| COMPASS Pathways Plc - American Depository Shares | CMPS | 5 | 3 | 2 | 40.0 |
| Rhythm Pharmaceuticals, Inc. - Common Stock | RYTM | 5 | 3 | 2 | 40.0 |
| Savara, Inc. - Common Stock | SVRA | 2 | 2 | 0 | 0.0 |
| Medpace Holdings, Inc. - Common Stock | MEDP | 8 | 7 | 1 | 12.5 |
| Ionis Pharmaceuticals, Inc. - Common Stock | IONS | 8 | 5 | 3 | 37.5 |
| Allogene Therapeutics, Inc. - Common Stock | ALLO | 7 | 7 | 0 | 0.0 |
| Caris Life Sciences, Inc. - Common Stock | CAI | 6 | 6 | 0 | 0.0 |
| Maze Therapeutics, Inc. - Common Stock | MAZE | 3 | 1 | 2 | 66.7 |
| Roivant Sciences Ltd. - Common Shares | ROIV | 4 | 2 | 2 | 50.0 |
| BioAge Labs, Inc. - Common Stock | BIOA | 9 | 4 | 5 | 55.6 |
| LENZ Therapeutics, Inc. - Common Stock | LENZ | 1 | 1 | 0 | 0.0 |
| REGENXBIO Inc. - Common Stock | RGNX | 6 | 6 | 0 | 0.0 |
| Mesoblast Limited - American Depositary Shares | MESO | 37 | 33 | 4 | 10.8 |
| Vanda Pharmaceuticals Inc. - Common Stock | VNDA | 6 | 4 | 2 | 33.3 |
| Cullinan Therapeutics, Inc. - Common Stock | CGEM | 5 | 5 | 0 | 0.0 |
| Rapport Therapeutics, Inc. - Common Stock | RAPP | 2 | 1 | 1 | 50.0 |
| Alto Neuroscience, Inc. Common Stock | ANRO | 3 | 2 | 1 | 33.3 |
| Kura Oncology, Inc. - Common Stock | KURA | 9 | 5 | 4 | 44.4 |
| Immunocore Holdings plc - American Depositary Shares | IMCR | 2 | 2 | 0 | 0.0 |
| Incyte Corporation - Common Stock | INCY | 8 | 6 | 2 | 25.0 |
| Celcuity Inc. - Common Stock | CELC | 6 | 4 | 2 | 33.3 |
| Xencor, Inc. - Common Stock | XNCR | 4 | 3 | 1 | 25.0 |
| ImmunityBio, Inc. - Common Stock | IBRX | 8 | 7 | 1 | 12.5 |
| Enliven Therapeutics, Inc. - Common Stock | ELVN | 3 | 1 | 2 | 66.7 |
| United Therapeutics Corporation - Common Stock | UTHR | 5 | 2 | 3 | 60.0 |